| Authors: |
Thorpe LM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.; Program in Virology, Harvard Medical School, Boston, MA 02115., Spangle JM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115., Ohlson CE; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115., Cheng H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115., Roberts TM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115., Cantley LC; Weill Cornell Medical Center, New York, NY 10065 lcantley@med.cornell.edu jean_zhao@dfci.harvard.edu., Zhao JJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115; lcantley@med.cornell.edu jean_zhao@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115. |